Early-life Immune Activation is a Vulnerability Factor for Adult Epileptogenesis in Neurofibromatosis Type 1 in Male Mice

Overview

Journal Front Neurol

Specialty Neurology

Date 2024 Apr 30

PMID 38685949

Authors

Rania Faidi

Aylin Y Reid

Affiliations

Soon will be listed here.

Abstract

Introduction: Patients with Neurofibromatosis type 1 (NF1), the most common neurocutaneous disorder, can develop several neurological manifestations that include cognitive impairments and epilepsy over their lifetime. It is unclear why certain patients with NF1 develop these conditions while others do not. Early-life immune activation promotes later-life seizure susceptibility, neurocognitive impairments, and leads to spontaneous seizures in some animal models of neurodevelopmental disorders, but the central nervous system immune profile and the enduring consequences of early-life immune activation on the developmental trajectory of the brain in NF1 have not yet been explored. We tested the hypothesis that early-life immune activation promotes the development of spatial memory impairments and epileptogenesis in a mouse model of NF1.

Methods: Male wild-type (WT) and mice received systemic lipopolysaccharide (LPS) or saline at post-natal day 10 and were assessed in adulthood for learning and memory deficits in the Barnes maze and underwent EEG recordings to look for spontaneous epileptiform abnormalities and susceptibility to challenge with pentylenetetrazole (PTZ).

Results: Whereas early-life immune activation by a single injection of LPS acutely elicited a comparable brain cytokine signature in WT and mice, it promoted spontaneous seizure activity in adulthood only in the mice. Early-life immune activation affected susceptibility to PTZ-induced seizures similarly in both WT and mice. There was no effect on spatial learning and memory regardless of mouse genotype.

Discussion: Our findings suggest environmental events such as early-life immune activation may promote epileptogenesis in the mouse and may be a risk-factor for NF1-associated epilepsy.

References

Harre E, Galic M, Mouihate A, Noorbakhsh F, Pittman Q . Neonatal inflammation produces selective behavioural deficits and alters N-methyl-D-aspartate receptor subunit mRNA in the adult rat brain. Eur J Neurosci. 2008; 27(3):644-53. PMC: 3547975. DOI: 10.1111/j.1460-9568.2008.06031.x. View

Farschtschi S, Park S, Sawitzki B, Oh S, Kluwe L, Mautner V . Effector T cell subclasses associate with tumor burden in neurofibromatosis type 1 patients. Cancer Immunol Immunother. 2016; 65(9):1113-21. PMC: 4995232. DOI: 10.1007/s00262-016-1871-0. View

Husi H, Ward M, Choudhary J, Blackstock W, Grant S . Proteomic analysis of NMDA receptor-adhesion protein signaling complexes. Nat Neurosci. 2000; 3(7):661-9. DOI: 10.1038/76615. View

Dinel A, Joffre C, Trifilieff P, Aubert A, Foury A, Le Ruyet P . Inflammation early in life is a vulnerability factor for emotional behavior at adolescence and for lipopolysaccharide-induced spatial memory and neurogenesis alteration at adulthood. J Neuroinflammation. 2014; 11:155. PMC: 4172903. DOI: 10.1186/s12974-014-0155-x. View

Solek C, Farooqi N, Verly M, Lim T, Ruthazer E . Maternal immune activation in neurodevelopmental disorders. Dev Dyn. 2017; 247(4):588-619. DOI: 10.1002/dvdy.24612. View

Silva A, Frankland P, Marowitz Z, Friedman E, Laszlo G, Cioffi D . A mouse model for the learning and memory deficits associated with neurofibromatosis type I. Nat Genet. 1997; 15(3):281-4. DOI: 10.1038/ng0397-281. View

Nadler J, Perry B, Cotman C . Intraventricular kainic acid preferentially destroys hippocampal pyramidal cells. Nature. 1978; 271(5646):676-7. DOI: 10.1038/271676a0. View

Shofty B, Constantini S, Ben-Shachar S . Advances in Molecular Diagnosis of Neurofibromatosis Type 1. Semin Pediatr Neurol. 2015; 22(4):234-9. DOI: 10.1016/j.spen.2015.10.007. View

Chen Y, Kuo T, Chu M, Ma H, Chiang Y, Yi-Kung Huang E . Postnatal systemic inflammation exacerbates impairment of hippocampal synaptic plasticity in an animal seizure model. Neuroimmunomodulation. 2013; 20(4):223-32. DOI: 10.1159/000348440. View

10.

Stafstrom C, Staedtke V, Comi A . Epilepsy Mechanisms in Neurocutaneous Disorders: Tuberous Sclerosis Complex, Neurofibromatosis Type 1, and Sturge-Weber Syndrome. Front Neurol. 2017; 8:87. PMC: 5355446. DOI: 10.3389/fneur.2017.00087. View

11.

Bernardo P, Cinalli G, Santoro C . Epilepsy in NF1: a systematic review of the literature. Childs Nerv Syst. 2020; 36(10):2333-2350. DOI: 10.1007/s00381-020-04710-7. View

12.

Ravizza T, Terrone G, Salamone A, Frigerio F, Balosso S, Antoine D . High Mobility Group Box 1 is a novel pathogenic factor and a mechanistic biomarker for epilepsy. Brain Behav Immun. 2017; 72:14-21. DOI: 10.1016/j.bbi.2017.10.008. View

13.

Sun Y, Vestergaard M, Christensen J, Nahmias A, Olsen J . Prenatal exposure to maternal infections and epilepsy in childhood: a population-based cohort study. Pediatrics. 2008; 121(5):e1100-7. DOI: 10.1542/peds.2007-2316. View

14.

Weiss B, Bollag G, Shannon K . Hyperactive Ras as a therapeutic target in neurofibromatosis type 1. Am J Med Genet. 1999; 89(1):14-22. View

15.

Pecoraro A, Arehart E, Gallentine W, Radtke R, Smith E, Pizoli C . Epilepsy in neurofibromatosis type 1. Epilepsy Behav. 2017; 73:137-141. DOI: 10.1016/j.yebeh.2017.05.011. View

16.

Park S, Sawitzki B, Kluwe L, Mautner V, Holtkamp N, Kurtz A . Serum biomarkers for neurofibromatosis type 1 and early detection of malignant peripheral nerve-sheath tumors. BMC Med. 2013; 11:109. PMC: 3648455. DOI: 10.1186/1741-7015-11-109. View

17.

Sorrentino U, Bellonzi S, Mozzato C, Brasson V, Toldo I, Parrozzani R . Epilepsy in NF1: Epidemiologic, Genetic, and Clinical Features. A Monocentric Retrospective Study in a Cohort of 784 Patients. Cancers (Basel). 2021; 13(24). PMC: 8699608. DOI: 10.3390/cancers13246336. View

18.

Walker 2nd W, Bumgarner J, Nelson R, DeVries A . Transcardial perfusion is not required to accurately measure cytokines within the brain. J Neurosci Methods. 2020; 334:108601. PMC: 7374017. DOI: 10.1016/j.jneumeth.2020.108601. View

19.

Ramanjaneyulu R, Ticku M . Interactions of pentamethylenetetrazole and tetrazole analogues with the picrotoxinin site of the benzodiazepine-GABA receptor-ionophore complex. Eur J Pharmacol. 1984; 98(3-4):337-45. DOI: 10.1016/0014-2999(84)90282-6. View

20.

Santoro C, Bernardo P, Coppola A, Pugliese U, Cirillo M, Giugliano T . Seizures in children with neurofibromatosis type 1: is neurofibromatosis type 1 enough?. Ital J Pediatr. 2018; 44(1):41. PMC: 5863905. DOI: 10.1186/s13052-018-0477-x. View